The Asia Pacific Anticoagulant Reversal Drugs Market would witness market growth of 14.6% CAGR during the forecast period (2021-2027). Anticoagulant reversal drugs aim to reverse the effect of anticoagulation in some specific situations like unplanned surgery, therapy including overdose of anticoagulant, and excessive bleeding. Anticoagulant reversal drugs are useful in the treatment of different medical conditions like venous thromboembolism, mechanical valve replacement, and atrial fibrillation (AF). It is also used in coagulation disorders like Factor V Leiden and antiphospholipid antibody syndrome. The factor like the increasing prevalence of atrial fibrillation (AFib) and cardiac stroke is acting as a catalyst for global market. Though, growth of the market would be hampered by the the huge cost of anticoagulant reversal drugs.
The major contributing factors to the market growth include the increasing prevalence of multiple cardiovascular indications and atrial fibrillation across the world. The increase in intracranial and gastrointestinal hemorrhages and the increasing geriatric population around the world are also propelling the demand for anticoagulant reversal drugs. According to the World Health Organization, more than 17.9 million people die due to different kinds of cardiovascular diseases each year around the globe. It is about 35% of global deaths. Moreover, 85% of these cardiovascular disease deaths are caused by heart attack and stroke. The increasing approval of blockbuster drug and the presence of a strong pipeline of products among key players will also play a pivotal role in helping the market to expand further.
In the Asia Pacific, there is an increasing number of cases for bleeding disorders among people. The introduction of new drugs and therapeutics and the cases requiring anticoagulant therapies in this region are major factors anticipated to boost the market growth during the forecast period. Atrial fibrillation (AF) is a type of commonly sustained arrhythmia that increased mortality and stroke rate among the people of Asia. As the Asian population is swiftly aging the expected population suffering from AF will reach nearly 72 million. The Asia Pacific will grow at the fastest rate in coming years with the increment in the number of patients suffering from diseases like strokes, atrial fibrillation, and other cardiopulmonary diseases. Ongoing trials of anticoagulant drugs in this region will further drive regional market growth.
The Idarucizumab market dominated the Singapore Anticoagulant Reversal Drugs Market by Product Type in 2020, thereby, achieving a market value of $8.5 million by 2027. The Andexanet Alfa market is estimated to grow at a CAGR of 14.7% during (2021-2027). Additionally, The Prothrombin Complex Concentrates market is expected to witness highest CAGR of 16.1% during (2021-2027).
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Retail Pharmacy and Online Pharmacy. Based on Product Type, the market is segmented into Idarucizumab, Andexanet Alfa, Prothrombin Complex Concentrates, Phytonadione, Protamine and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Anticoagulant Reversal Drugs Market is Projected to reach USD 1.6 Billion by 2027, at a CAGR of 13.3%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boehringer Ingelheim International GmbH, CSL Limited, Bausch Health Companies, Inc., Octapharma AG, Pfizer, Inc., Fresenius SE & Co. KGaA, Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals), Dr. Reddy’s Laboratories Ltd., AMAG Pharmaceuticals, Inc. (Covis Pharma), and Alps Pharmaceutical Ind. Co., Ltd.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Product Type
- Idarucizumab
- Andexanet Alfa
- Prothrombin Complex Concentrates
- Phytonadione
- Protamine
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Boehringer Ingelheim International GmbH
- CSL Limited
- Bausch Health Companies, Inc.
- Octapharma AG
- Pfizer, Inc.
- Fresenius SE & Co. KGaA
- Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- Dr. Reddy’s Laboratories Ltd.
- AMAG Pharmaceuticals, Inc. (Covis Pharma)
- Alps Pharmaceutical Ind. Co., Ltd.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Anticoagulant Reversal Drugs Market, by Distribution Channel
1.4.2 Asia Pacific Anticoagulant Reversal Drugs Market, by Product Type
1.4.3 Asia Pacific Anticoagulant Reversal Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition:
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Opportunities:
Chapter 3. Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel
3.1 Asia Pacific Hospital Pharmacy Market by Country
3.2 Asia Pacific Retail Pharmacy Market by Country
3.3 Asia Pacific Online Pharmacy Market by Country
Chapter 4. Asia Pacific Anticoagulant Reversal Drugs Market by Product Type
4.1 Asia Pacific Idarucizumab Market by Country
4.2 Asia Pacific Andexanet Alfa Market by Country
4.3 Asia Pacific Prothrombin Complex Concentrates Market by Country
4.4 Asia Pacific Phytonadione Market by Country
4.5 Asia Pacific Other Product Type Market by Country
Chapter 5. Asia Pacific Anticoagulant Reversal Drugs Market by Country
5.1 China Anticoagulant Reversal Drugs Market
5.1.1 China Anticoagulant Reversal Drugs Market by Distribution Channel
5.1.2 China Anticoagulant Reversal Drugs Market by Product Type
5.2 Japan Anticoagulant Reversal Drugs Market
5.2.1 Japan Anticoagulant Reversal Drugs Market by Distribution Channel
5.2.2 Japan Anticoagulant Reversal Drugs Market by Product Type
5.3 India Anticoagulant Reversal Drugs Market
5.3.1 India Anticoagulant Reversal Drugs Market by Distribution Channel
5.3.2 India Anticoagulant Reversal Drugs Market by Product Type
5.4 South Korea Anticoagulant Reversal Drugs Market
5.4.1 South Korea Anticoagulant Reversal Drugs Market by Distribution Channel
5.4.2 South Korea Anticoagulant Reversal Drugs Market by Product Type
5.5 Singapore Anticoagulant Reversal Drugs Market
5.5.1 Singapore Anticoagulant Reversal Drugs Market by Distribution Channel
5.5.2 Singapore Anticoagulant Reversal Drugs Market by Product Type
5.6 Malaysia Anticoagulant Reversal Drugs Market
5.6.1 Malaysia Anticoagulant Reversal Drugs Market by Distribution Channel
5.6.2 Malaysia Anticoagulant Reversal Drugs Market by Product Type
5.7 Rest of Asia Pacific Anticoagulant Reversal Drugs Market
5.7.1 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel
5.7.2 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Product Type
Chapter 6. Company Profiles
6.1 Boehringer Ingelheim International GmbH
6.1.1 Company Overview
6.1.2 Financial Analysis
6.1.3 Regional & Segmental Analysis
6.1.4 Research & Development Expenses
6.2 CSL Limited
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.3 Bausch Health Companies, Inc.
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.4 Octapharma AG
6.4.1 Company Overview
6.5 Pfizer, Inc.
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Regional Analysis
6.5.4 Research & Development Expense
6.6 Fresenius SE & Co. KGaA
6.6.1 Company Overview
6.6.2 Financial Analysis
6.6.3 Segmental and Regional Analysis
6.6.4 Research & Development Expenses
6.7 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
6.7.1 Company Overview
6.7.2 Financial Analysis
6.7.3 Regional Analysis
6.7.4 Research & Development Expense
6.7.5 Recent strategies and developments:
6.7.5.1 Approvals:
6.8 Dr. Reddy’s Laboratories Ltd.
6.8.1 Company Overview
6.8.2 Financial Analysis
6.8.3 Segmental and Regional Analysis
6.8.4 Research & Development Expense
6.9 AMAG Pharmaceuticals, Inc. (Covis Pharma)
6.9.1 Company Overview
6.9.2 Financial Analysis
6.9.3 Research & Development Expenses
6.9.4 Recent strategies and developments:
6.9.4.1 Partnerships, Collaborations, and Agreements:
6.9.4.2 Acquisition and Mergers:
6.10. Alps Pharmaceutical Ind. Co., Ltd.
6.10.1 Company Overview
TABLE 1 Asia Pacific Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 2 Asia Pacific Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 3 Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 4 Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 5 Asia Pacific Hospital Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 6 Asia Pacific Hospital Pharmacy Market by Country, 2021-2027, USD Million
TABLE 7 Asia Pacific Retail Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 8 Asia Pacific Retail Pharmacy Market by Country, 2021-2027, USD Million
TABLE 9 Asia Pacific Online Pharmacy Market by Country, 2017 - 2020, USD Million
TABLE 10 Asia Pacific Online Pharmacy Market by Country, 2021-2027, USD Million
TABLE 11 Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 12 Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 13 Asia Pacific Idarucizumab Market by Country, 2017 - 2020, USD Million
TABLE 14 Asia Pacific Idarucizumab Market by Country, 2021-2027, USD Million
TABLE 15 Asia Pacific Andexanet Alfa Market by Country, 2017 - 2020, USD Million
TABLE 16 Asia Pacific Andexanet Alfa Market by Country, 2021-2027, USD Million
TABLE 17 Asia Pacific Prothrombin Complex Concentrates Market by Country, 2017 - 2020, USD Million
TABLE 18 Asia Pacific Prothrombin Complex Concentrates Market by Country, 2021-2027, USD Million
TABLE 19 Asia Pacific Phytonadione Market by Country, 2017 - 2020, USD Million
TABLE 20 Asia Pacific Phytonadione Market by Country, 2021-2027, USD Million
TABLE 21 Asia Pacific Other Product Type Market by Country, 2017 - 2020, USD Million
TABLE 22 Asia Pacific Other Product Type Market by Country, 2021-2027, USD Million
TABLE 23 Asia Pacific Anticoagulant Reversal Drugs Market by Country, 2017 - 2020, USD Million
TABLE 24 Asia Pacific Anticoagulant Reversal Drugs Market by Country, 2021-2027, USD Million
TABLE 25 China Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 26 China Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 27 China Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 28 China Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 29 China Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 30 China Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 31 Japan Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 32 Japan Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 33 Japan Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 34 Japan Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 35 Japan Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 36 Japan Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 37 India Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 38 India Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 39 India Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 40 India Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 41 India Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 42 India Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 43 South Korea Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 44 South Korea Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 45 South Korea Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 46 South Korea Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 47 South Korea Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 48 South Korea Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 49 Singapore Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 50 Singapore Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 51 Singapore Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 52 Singapore Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 53 Singapore Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 54 Singapore Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 55 Malaysia Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 56 Malaysia Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 57 Malaysia Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 58 Malaysia Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 59 Malaysia Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 60 Malaysia Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 61 Rest of Asia Pacific Anticoagulant Reversal Drugs Market, 2017 - 2020, USD Million
TABLE 62 Rest of Asia Pacific Anticoagulant Reversal Drugs Market, 2021-2027, USD Million
TABLE 63 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2017 - 2020, USD Million
TABLE 64 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Distribution Channel, 2021-2027, USD Million
TABLE 65 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2017 - 2020, USD Million
TABLE 66 Rest of Asia Pacific Anticoagulant Reversal Drugs Market by Product Type, 2021-2027, USD Million
TABLE 67 Key Information – Boehringer Ingelheim International GmbH
TABLE 68 key Information – CSL Limited
TABLE 69 key information – Bausch Health Companies, Inc.
TABLE 70 Key Information – Octapharma AG
TABLE 71 Key Information – Pfizer, Inc.
TABLE 72 key information – Fresenius SE & Co. KGaA
TABLE 73 key information – Alexion Pharmaceuticals, Inc.
TABLE 74 key information – Dr. Reddy’s Laboratories Ltd.
TABLE 75 key information – AMAG Pharmaceuticals, Inc.
TABLE 76 key information – Alps Pharmaceutical Ind. Co., Ltd.
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: AMAG Pharmaceuticals, Inc.